Asthma and Respiratory Foundation NZ
Menu
Donate
Asthma and Respiratory Foundation NZ
In this section
Filter by topic:
All Asthma COPD Research Bronchiectasis Lung cancer Obstructive sleep apnoea Housing Smoking Management plans Other conditions Access to primary care Health literacy Poverty Health workforce Social determinants IPF Vaping COVID-19

Effect of Antimicrobial Therapy on Respiratory Hospitalization or Death in Adults With Idiopathic Pulmonary Fibrosis - The CleanUP-IPF Randomized Clinical Trial:

Fernando J. Martinez, MD, MS; Eric Yow, MS; Kevin R. Flaherty, MD; et al

11 May, 2021

NZ Respiratory Research Review Issue 189

Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial:

Prof Jürgen Behr, MD Prof Antje Prasse, MD Prof Michael Kreuter, MD Johannes Johow, PhD Prof Klaus F Rabe, MD Prof Francesco Bonella, MD et al.

30 March, 2021

NZ Respiratory Research Review Issue 189

Pirfenidone plus inhaled N-acetylcysteine for idiopathic pulmonary fibrosis: a randomised trial:

Susumu Sakamoto, Kensuke Kataoka, Yasuhiro Kondoh, Motoyasu Kato, Masaki Okamoto, Hiroshi Mukae, Masashi Bando, Takafumi Suda, Kazuhiro Yatera, Yoshinori Tanino, Tomoo Kishaba, Noboru Hattori, Yoshio Taguchi, Takefumi Saito, Yasuhiko Nishioka, Kazuyoshi Kuwano, Kazuma Kishi, Naohiko Inase, Shinichi Sasaki, Hajime Takizawa, Takeshi Johkoh, Fumikazu Sakai, Sakae Homma the Diffuse Lung Diseases Research Group of the Ministry of Health, Labour and Welfare, Japan

5 January, 2021

NZ Respiratory Research Review Issue 189

Cause of mortality and sarcopenia in patients with idiopathic pulmonary fibrosis receiving antifibrotic therapy:

Yuzo Suzuki, Yuya Aono, Masato Kono, Hirotsugu Hasegawa, Koushi Yokomura, Hyogo Naoi, Hironao Hozumi, Masato Karayama, Kazuki Furuhashi, Noriyuki Enomoto, Tomoyuki Fujisawa, Yutaro Nakamura, Naoki Inui, Hidenori Nakamura, Takafumi Suda

23 September, 2020

NZ Respiratory Research Review Issue 189

Effectiveness of Proton Pump Inhibitors in Idiopathic Pulmonary Fibrosis - A Population-Based Cohort Study:

Tanja Tran, MSc Deborah Assayag, MD Pierre Ernst, MD Samy Suissa, PhD

31 August, 2020

NZ Respiratory Research Review Issue 189

Risk of cancer incidence in patients with idiopathic pulmonary fibrosis: A nationwide cohort study:

Hong Yeul Lee,Jinwoo Lee,Chang-Hoon Lee,Kyungdo Han,Sun Mi Choi

22 July, 2020

NZ Respiratory Research Review Issue 189

Peer Connect Service for people with pulmonary fibrosis in Australia: Participants' experiences and process evaluation:

Gabriella Tikellis,Joanna Y.T. Lee,Tamera J. Corte,Jamie Maloney,Michael Bartlett,Tonia Crawford,Ian N. Glaspole,Nicole Goh,Kelcie Herrmann,Alison J. Hey-Cunningham,Greg Keir,Yet H. Khor,John Price,Debra G. Sandford,Lissa Spencer,Alan Teoh,Jennifer Walsh,Susanne Webster,Anne E. Holland

23 March, 2020

NZ Respiratory Research Review Issue 189

Respiratory Research Review - Issue 152:

Professor Lutz Beckert

12 October, 2018

Respiratory research with a focus on ILD (interstitial lung disease)